HR 5127
114th Congress
House
Health
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Medical research
Curb Opioid Misuse By Advancing Technology Act of 2016
Introduced: April 29, 2016
Introduced by:
Griffith, H. Morgan
Republican
· Virginia
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 6, 2016
Referred to the Subcommittee on Health.
Apr 29, 2016
Referred to the House Committee on Energy and Commerce.
Apr 29, 2016
Introduced in House
Plain-English summary
Curb Opioid Misuse By Advancing Technology Act of 2016
This bill amends the Federal Food, Drug, and Cosmetic Act to extend the marketing exclusivity period for certain brand name drugs that the Food and Drug Administration approves: (1) on the basis of new clinical abuse potential studies, and (2) with labeling that characterizes the drug's abuse-deterrent properties. This extension does not apply to the marketing exclusivity period for new chemical entities.
The bill also extends the marketing exclusivity period for generics of these drugs.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2